Good Health and Well-Being
Organizer:
- Organized by
-
-
Cinacalcet: A Breakthrough in Managing Hyperparathyroidism
-
Cinacalcet: A Breakthrough in Managing Hyperparathyroidism
Cinacalcet is a widely used calcimimetic drug that helps regulate calcium levels in patients with secondary hyperparathyroidism (SHPT), primary hyperparathyroidism, and parathyroid carcinoma. By increasing the sensitivity of calcium-sensing receptors in the parathyroid gland, Cinacalcet effectively reduces parathyroid hormone (PTH) levels, preventing complications such as bone loss, kidney stones, and cardiovascular issues.
With the rising prevalence of chronic kidney disease (CKD) and related disorders, the demand for Cinacalcet has grown significantly. Leading Cinacalcet manufacturers in India play a crucial role in producing high-quality and affordable versions of this essential medication. These manufacturers follow stringent regulatory guidelines, ensuring that the drug meets global safety and efficacy standards.
India has become a key hub for pharmaceutical production, with Cinacalcet manufacturers in India focusing on large-scale production and cost-effective formulations to make the drug accessible worldwide. Their commitment to research, innovation, and efficient distribution ensures that patients receive reliable treatment for hyperparathyroidism.
-
0 Replies
Sorry, there were no replies found.
Log in to reply.